Defunct Company
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,440
NCT00912678
Minimizing Immunosuppression in Old for Old Kidney Transplantation
Phase: Phase 4
Role: Collaborator
Start: Mar 31, 2002
Completion: Oct 31, 2008
NCT00545493
Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis
Phase: Phase 2/3
Start: Nov 30, 2002
Completion: Apr 30, 2010
NCT00147381
Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection
Phase: Phase 3
Start: Jan 31, 2004
Completion: Jul 31, 2011
NCT00316810
Simultaneous Pancreas-kidney Transplantation With Campath Protocol
Start: Apr 30, 2006
Completion: Jun 30, 2011
NCT00565331
Rituximab for Prevention of Rejection After Renal Transplantation
Start: Dec 31, 2007
Completion: Jun 30, 2015
NCT00724022
Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
Start: Jun 30, 2008
Completion: Jul 31, 2014
NCT01523951
Topical Local Anaesthesia and Cooling During Capsaicin 8% Patch Application
Phase: N/A
Start: Jan 31, 2012
Completion: Mar 31, 2012
NCT02570841
Pain Thresholds Under High-dose Topical Capsaicin
Start: Feb 28, 2015
Completion: Sep 30, 2015
NCT06097533
Improvement of Quality of Life by Cannabinoids in Oncologic Patients
Phase: Phase 2
Start: Apr 8, 2024
Completion: Nov 30, 2026
NCT07110038
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
Start: Oct 31, 2025
Completion: Nov 30, 2030